Artiva Biotherapeutics (ARTV) Other Non-Current Assets (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Other Non-Current Assets data on file, last reported at $458000.0 in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $458000.0, down 0.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $458000.0 (down 0.65% YoY), and the FY2025 annual result was $461000.0, up 72.66% from the prior year.
• Other Non-Current Assets slipped to $458000.0 in Q1 2026 per ARTV's latest filing, from $461000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $461000.0 in Q1 2025 and troughed at $38000.0 in Q2 2025.
• A 4-year average of $319000.0 and a median of $262500.0 in 2023 frame the typical range for Other Non-Current Assets.
• On a YoY basis, Other Non-Current Assets climbed as much as 78.68% in 2025 and fell as far as 85.27% in 2025.
• A 4-year view of Other Non-Current Assets shows it stood at $392000.0 in 2023, then tumbled by 31.89% to $267000.0 in 2024, then jumped by 72.66% to $461000.0 in 2025, then dropped by 0.65% to $458000.0 in 2026.
• Business Quant data shows ARTV's Other Non-Current Assets at $458000.0 in Q1 2026, $461000.0 in Q4 2025, and $461000.0 in Q3 2025.